Spero Therapeutics Statistics
Total Valuation
SPRO has a market cap or net worth of $36.89 million. The enterprise value is -$6.36 million.
Important Dates
The last earnings date was Tuesday, May 13, 2025, after market close.
| Earnings Date | May 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
SPRO has 55.90 million shares outstanding. The number of shares has increased by 2.37% in one year.
| Current Share Class | 55.90M |
| Shares Outstanding | 55.90M |
| Shares Change (YoY) | +2.37% |
| Shares Change (QoQ) | +1.54% |
| Owned by Insiders (%) | 2.13% |
| Owned by Institutions (%) | 21.10% |
| Float | 41.68M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.84 |
| Forward PS | n/a |
| PB Ratio | 1.14 |
| P/TBV Ratio | 1.14 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.56, with a Debt / Equity ratio of 0.12.
| Current Ratio | 2.56 |
| Quick Ratio | 2.51 |
| Debt / Equity | 0.12 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -107.28% and return on invested capital (ROIC) is -65.57%.
| Return on Equity (ROE) | -107.28% |
| Return on Assets (ROA) | -37.21% |
| Return on Invested Capital (ROIC) | -65.57% |
| Return on Capital Employed (ROCE) | -150.47% |
| Revenue Per Employee | $1.39M |
| Profits Per Employee | -$2.18M |
| Employee Count | 32 |
| Asset Turnover | 0.36 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -58.62% in the last 52 weeks. The beta is 0.23, so SPRO's price volatility has been lower than the market average.
| Beta (5Y) | 0.23 |
| 52-Week Price Change | -58.62% |
| 50-Day Moving Average | 0.71 |
| 200-Day Moving Average | 1.03 |
| Relative Strength Index (RSI) | 52.32 |
| Average Volume (20 Days) | 96,235 |
Short Selling Information
The latest short interest is 645,163, so 1.15% of the outstanding shares have been sold short.
| Short Interest | 645,163 |
| Short Previous Month | 801,304 |
| Short % of Shares Out | 1.15% |
| Short % of Float | 1.55% |
| Short Ratio (days to cover) | 3.79 |
Income Statement
In the last 12 months, SPRO had revenue of $44.58 million and -$69.76 million in losses. Loss per share was -$1.28.
| Revenue | 44.58M |
| Gross Profit | -52.17M |
| Operating Income | -73.06M |
| Pretax Income | 20.05M |
| Net Income | -69.76M |
| EBITDA | -73.15M |
| EBIT | -73.06M |
| Loss Per Share | -$1.28 |
Full Income StatementBalance Sheet
The company has $48.89 million in cash and $3.96 million in debt, giving a net cash position of $44.93 million or $0.80 per share.
| Cash & Cash Equivalents | 48.89M |
| Total Debt | 3.96M |
| Net Cash | 44.93M |
| Net Cash Per Share | $0.80 |
| Equity (Book Value) | 33.81M |
| Book Value Per Share | 0.60 |
| Working Capital | 45.56M |
Full Balance SheetCash Flow
| Operating Cash Flow | -33.38M |
| Capital Expenditures | n/a |
| Free Cash Flow | -33.38M |
| FCF Per Share | -$0.60 |
Full Cash Flow StatementMargins
Gross margin is -117.02%, with operating and profit margins of -163.87% and -156.48%.
| Gross Margin | -117.02% |
| Operating Margin | -163.87% |
| Pretax Margin | -156.48% |
| Profit Margin | -156.48% |
| EBITDA Margin | -164.07% |
| EBIT Margin | -163.87% |
| FCF Margin | n/a |